UNSPSC 51343512: Tenofovir disoproxil fumarate

This classification denotes a reverse transcriptase inhibitor with the molecular formula C19H30N5O10P.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OTT9J7900I, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but more generally known as tenofovir disoproxil fumarate, which bears US NIH Compound Identifier 464205. European Medicines Agency schedules Tenofovir disoproxil fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12607MIG.

UNSPSC 51343512 Tenofovir disoproxil fumarate, a Commodity code, shows minimal alignment between its nominal scope and the recent state and local procurement activity tagged under it. The code specifies a single antiretroviral pharmaceutical ingredient, but the recent opportunities posted under this code procure emergency-response medical supplies, naloxone, pharmacy benefit management systems, and generic multi-source pharmaceuticals—none of which are tenofovir disoproxil fumarate or directly related products. State and local procurement classification systems occasionally tag opportunities with UNSPSC codes that do not match the actual goods or services being bought, and this code exemplifies that mismatch. The issuing bodies include county health departments (Seminole County, Florida), municipal fire services (City of Tampa), state health commissions (Texas HHS Commission), and multi-state cooperative purchasing alliances (MMCAP), but none of these solicitations target the specific pharmaceutical ingredient named in the code.

The recent opportunities span Florida, Texas, Minnesota, and Oregon, but they address distinct procurement categories—emergency medical supplies through an IFB, direct-to-manufacturer pharmacy programs through an RFI, fire-department medical equipment through an IFB, and generic pharmaceuticals through an RFP—rather than antiretroviral medications. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) seeks naloxone and drug deactivation systems for community health; the City of Tampa IFB (26P00145, due March 13, 2026) procures medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 and a 5% Small Local Business Enterprise bid discount; the Texas HHS RFI (HHS0017013, posted April 3, 2026) explores direct-to-manufacturer prescription programs; and MMCAP's RFP (S1070000015802, due March 26, 2026) establishes contracts for generic multi-source pharmaceuticals and OTC products across state and local facilities. The code shows no recent activity that genuinely reflects procurement of tenofovir disoproxil fumarate or closely related antiretroviral therapies.